Technologies

Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of ‘Neurophet AQUA AD’

  • by

​ Demonstrated brain imaging analysis solutions, including ‘Neurophet AQUA AD,’ which enables monitoring of adverse effects associated with Alzheimer’s disease treatments Highlighted clinical cases that improved the safety of anti-amyloid therapy administration during an AI… Read More »Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of ‘Neurophet AQUA AD’